Keros Therapeutics, Inc. · NASDAQ:KROS
Newton Charles W. sold 550 Keros Therapeutics, Inc. shares (Form 4)
Traded Jun 11, 2026 · Filed Jun 15, 2026
On Jun 11, 2026, Newton Charles W. (Director) sold 550 Keros Therapeutics, Inc. shares at US$10.04 for US$5,522 under a trading plan, leaving 12,665 shares. Filed Jun 15, 2026 (Form 4).
- Sold
- 550 shares
- Price
- US$10.04
- Value
- US$5,522
- Holding after
- 12,665 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | Sale | 550 | US$10.04 | 12,665 | Direct |
Source
Related
- Keros Therapeutics, Inc.
- Newton Charles W.
- Keros Therapeutics, Inc. shareholders
- Form 4 · Newton Charles W. · Aug 20, 2026
- Form 4 · Tanini Annita · Aug 20, 2026
- Form 4 · Lerner Lorena Raquel · Aug 20, 2026
- Form 4 · Cho Esther · Aug 20, 2026
- Form 4 · Bienaime Jean Jacques · Aug 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026